For decades, nuclear energy development stalled in a classic 'chicken and egg' problem: you needed data to get regulatory approval, but you needed an operational plant to get that data. Isaiah Taylor, founder and CEO of Valor Atomics, points to this as a primary reason the industry struggled, churning out "paper reactors" with complex models but no real-world proof.

Then, executive orders like EO14301 pulled a forgotten trick from the past: the Department of Energy pathway. This wasn't some new bureaucratic layer; it was the original congressional intent for nuclear R&D. Valor Atomics used it to fire up an advanced reactor, generating crucial data and breaking the cycle. For ambitious founders facing similar regulatory grids, Taylor's story isn't just about nuclear—it's a playbook for finding hidden paths through seemingly impossible bottlenecks.

Key Takeaways

  • The nuclear industry's core regulatory slowdown stemmed from a 'chicken and egg' problem: needing operational data for approval, but needing approval to operate.
  • Valor Atomics' reactor, now making 100 kilowatts and splitting 10^17 atoms per second, was turned on under an executive order (EO14301) using the Department of Energy's (DOE) original research and development authority.
  • The DOE pathway, initially conceived as the Energy Research and Development Agency (ERDA), was explicitly designed for testing and R&D, separate from the NRC's commercial deployment focus.
  • This reactivated legal framework allows companies to gather critical operational data, circumventing traditional delays by operating outside the commercial regulatory lens.
  • Understanding how Valor Atomics exploited this historical bypass is the first step in applying The Department of Energy Pathway for Nuclear R&D Acceleration to your own industry.

The Department of Energy Pathway for Nuclear R&D Acceleration

This framework, resurrected for companies like Valor Atomics, offers a distinct approach to product development in highly regulated, hardware-heavy industries.

  • Problem (The Chicken and Egg): You need data in order to go to the regulator, but in order to go to the regulator with data, you have to have run a plant.
  • Failed Traditional Solution: modeling and simulation... producing very, very precise what we call paper reactors which have really good predictions of how a theoretical thing might behave.
  • Original Congressional Intent: there were actually two pathways for nuclear in the United States. There was the testing pathway and the commercial pathway.
  • Commercial Pathway (NRC): the NRC the nuclear regulatory commission. The NRC is solving for large-scale commercial deployment of mature systems.
  • Testing Pathway (DOE/ERDA): the Department of Energy... originally called the ERDA, the Energy Research and Development Agency... its origin is actually a spin out of the Atomic Energy Commission... the ERDA in charge of testing, and we'll have these just two two separate agencies... But the origin of this agency is testing nuclear reactors. That's that's what it's for.
  • Enabling Factor: been waiting for an administration to say, 'Hey, this might be a way to accelerate nuclear R&D.' Uh, and that's exactly what the Trump administration has done. So, the reactor that's uh behind us here um was turned on under an executive order. It was EO14301, which called for three advanced reactors to go critical on American soil by July 4th. Um and and we built it under Department of Energy uh authority under that executive order.

When This Works (and When It Doesn't)

Isaiah Taylor makes it clear: “This is really breaking that chicken and egg... It's the first time where we've been able to to shortcut that... and we have data now.” This pathway works specifically for R&D phases in industries where physical testing is mandatory, but commercial regulatory bodies impose data requirements that preclude early operational trials. It needs a governmental entity with a specific, often historical, mandate for research, separate from commercial oversight. It works best when executive action or similar political will reactivates or supports these existing but underutilized frameworks.

This method won't apply to every startup. It's less effective for software or purely digital products, where iteration cycles are already rapid and regulatory hurdles are different. It also requires navigating federal or institutional relationships, which can be slow and opaque. Furthermore, reliance on executive orders means vulnerability to shifts in administration or policy, adding a layer of risk to long-term R&D. But for specific hardware, biotech, or energy projects, it's a forgotten lever.

What to Do With This

If you're building physical hardware or deep tech in a heavily regulated industry—biotech, aerospace, advanced materials—pull your last three regulatory filings. Look for historical precedents or forgotten mandates within federal agencies or research institutions (like the DOE/ERDA). Could a specific agency, with an R&D-focused charter, offer a testing pathway distinct from commercial approval? Map out your regulatory 'chicken and egg' problem, then research whether an “Energy Research and Development Agency” equivalent exists in your domain, waiting for an executive nudge. Your next prototype might need a lab, not a commercial permit.